Why the study?
Does antihypertensive treatment with indapamide (sustained release), with or without perindopril, provide benefit in hypertensive patients 80 years of age or older?
Does antihypertensive treatment with indapamide (sustained release), with or without perindopril, provide benefit in hypertensive patients 80 years of age or older?
Antihypertensive treatment with indapamide (with or without perindopril) is beneficial in hypertensive patients aged 80 years or older.
Supports treatment of hypertension in patients ≥80 years; extends randomized evidence to the very elderly.
The results provide evidence that antihypertensive treatment with indapamide (sustained release), with or without perindopril, in persons 80 years of age or older is beneficial. (ClinicalTrials.gov number, NCT00122811 [ClinicalTrials.gov].).
No takes yet. Share an insight, caveat, or question.
Beckett et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: